Skip to content

Clinical trial: Comparison of the effects of continuous and short and long-term high interval training on rehabilitation of cardiovascular patients

Comparison of the effects of continuous and short and long-term high interval training on rehabilitation of cardiovascular patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015070123002N1
Enrollment
90
Registered
2016-01-09
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease post coronary artery bypass graft. Myocardial infarction specified as acute or with a stated duration of 4 weeks (28 days) or less from onset

Interventions

Intervention 1: Intervention group 1: moderate intensity contentious exercise (MICE) consist of 45 minutes at 70 % heart rate reserve, 3 session per week for 6 week. Warm- up and cool- down for patien
Rehabilitation
Intervention group 1: moderate intensity contentious exercise (MICE) consist of 45 minutes at 70 % heart rate reserve, 3 session per week for 6 week. Warm- up and cool- down for patients at the start
Intervention group 2: high intensity interval training-1 consist of: warm up 5 minutes at 50-55% heart rate reserve, and 5×4 minutes at 85-90% heart rate reserve and 3 minutes active period interval a
Intervention group 3 : high intensity interval training-2 consist of: warm up 5 minutes at 50-55% heart rate reserve, and 9×2 minutes at 85-90% heart rate reserve and 3 minutes active period interval
Control group: No any exercise training program and maintain daily activities

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: sinus rhythm,left ventricular ejection fraction =50% and 4- 16 week after coronary artery bypass graft surgery; Exclusion criteria: coexisting valvular and/or peripheral vascular diseases, frequent atrial or ventricular premature beats, conduction defects, pericarditis, peripheral neuropathy, orthopedic or neurological limitations, cessation of drug use during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Resting heart rate. Timepoint: Befor and after 6 week. Method of measurement: Polar beat heart rate.;Ejection fraction. Timepoint: Befor and after 6 week intervention. Method of measurement: 2 dimentional echocardiography.;Maximal heart rate. Timepoint: Befor and after 6 week intervention. Method of measurement: Polar beat heart rate.;Cardiad out put. Timepoint: Befor and after 6 week intervention. Method of measurement: 2 dimentional echocardiography.;Rate product pressure. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;End-systolic diameter. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;End-diastolic diameter. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;Stroke volume. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;Heart rate variabality. Timepoint: Befor and after 6 week of intervention. Method of measurement: Cardiac hollter monitoring.;Quality of life. Timepoint: Befor and after 6 week of intervention. Method of measurement: The World Health Organization Quality of Life Questionnaire.;Plasma glucose level. Timepoint: Befor and after 6 week of intervention. Method of measurement: Enzymatic.;Serum triglycerides. Timepoint: Befor and after 6 week intervention. Method of measurement: Photometry.;Serum cholestrol. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Serum LDL. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Serum HDL. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Blood pressure. Timepoint: Befor and after 6 week of intervention. Method of measurement: Barometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Ghardashi Afousi

Baqiyatallah University of Medical Sciences

ghardashi.a@ut.ac.ir+98 21 8248 2402

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026